BioLife Solutions (BLFS) Short Interest Ratio & Short Volume → This Apple-like Innovator is Revolutionizing Healthcare (From Wall Street Star) (Ad) Free BLFS Stock Alerts $16.62 -0.57 (-3.32%) (As of 12:05 PM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media BioLife Solutions Short Interest DataCurrent Short Volume3,100,000 sharesPrevious Short Volume3,200,000 sharesChange Vs. Previous Month-3.13%Dollar Volume Sold Short$48.61 millionShort Interest Ratio / Days to Cover8.2Last Record DateApril 15, 2024Outstanding Shares45,300,000 sharesPercentage of Shares Shorted6.84%Today's Trading Volume146,634 sharesAverage Trading Volume407,960 sharesToday's Volume Vs. Average36% Short Selling BioLife Solutions ? Sign up to receive the latest short interest report for BioLife Solutions and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatBLFS Short Interest Over TimeBLFS Days to Cover Over TimeBLFS Percentage of Float Shorted Over Time Ad Stansberry ResearchSee this before next week's Fed meetingSee this before next week's Fed Meeting Doc Eifrig just released a new video detailing "the perilous moment Americans are in right now." Angry voters, mounting government debt, and blood in the streets… But he's got a way out – a unique way to come out on top no matter who wins this presidential election. (Last time we shared this, it led to a 995% gain.) Click here to see it. BioLife Solutions Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/20243,100,000 shares $48.61 million -3.1%N/A8.2 $15.68 3/31/20243,200,000 shares $59.36 million +5.6%N/A7.8 $18.55 3/15/20243,030,000 shares $52.48 million -7.6%N/A7.5 $17.32 2/29/20243,280,000 shares $55.43 million -7.6%N/A7.7 $16.90 2/15/20243,550,000 shares $64.57 million -1.9%N/A7.9 $18.19 1/31/20243,620,000 shares $61.54 million -10.6%N/A7.2 $17.00 Get the Latest News and Ratings for BLFS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for BioLife Solutions and its competitors with MarketBeat's FREE daily newsletter. 1/15/20244,050,000 shares $70.39 million +1.0%N/A7.1 $17.38 12/31/20234,010,000 shares $65.16 million -5.4%N/A7.3 $16.25 12/15/20234,240,000 shares $63.39 million +4.4%N/A7.9 $14.95 11/30/20234,060,000 shares $50.22 million -1.9%N/A7.5 $12.37 11/15/20234,140,000 shares $51.09 million +4.6%N/A7.9 $12.34 10/31/20233,960,000 shares $40.00 million -6.2%N/A7.3 $10.10 10/15/20234,220,000 shares $50.85 million +15.9%N/A8.3 $12.05 9/30/20233,640,000 shares $50.27 million +11.0%N/A7.9 $13.81 9/15/20233,280,000 shares $42.44 million +3.5%N/A7.2 $12.94 8/31/20233,170,000 shares $41.88 million +5.3%N/A7.4 $13.21 8/15/20233,010,000 shares $36.93 million -9.6%N/A7.8 $12.27 7/31/20233,330,000 shares $66.20 million +7.8%N/A9.3 $19.88 7/15/20233,090,000 shares $60.63 million +2.0%N/A9.8 $19.62 6/30/20233,030,000 shares $66.96 million +13.1%N/A9.9 $22.10 6/15/20232,680,000 shares $61.16 million +1.1%N/A8.8 $22.82 5/31/20232,650,000 shares $61.88 million +5.6%N/A8.5 $23.35 5/15/20232,510,000 shares $48.84 million +3.7%6.3%8.2 $19.46 4/30/20232,420,000 shares $42.50 million +2.5%6.1%8.8 $17.56 4/15/20232,360,000 shares $46.94 million +10.8%5.9%8 $19.89 3/31/20232,130,000 shares $46.33 million +0.5%5.3%6.6 $21.75 3/15/20232,120,000 shares $45.54 million +10.4%5.4%6.7 $21.48 2/28/20231,920,000 shares $44.66 million +3.2%4.9%6.1 $23.26 2/15/20231,860,000 shares $44.01 million -7.5%4.7%5.8 $23.66 1/31/20232,010,000 shares $47.11 million -13.7%5.1%5.3 $23.44 1/15/20232,330,000 shares $54.85 million -5.7%5.9%6.1 $23.54 12/30/20222,470,000 shares $44.95 million -2.4%6.2%6.6 $18.20 12/15/20222,530,000 shares $47.49 million -17.9%6.4%6.7 $18.77 11/30/20223,080,000 shares $65.20 million +1.7%7.8%8.3 $21.17 11/15/20223,030,000 shares $74.54 million +16.1%7.7%8.5 $24.60 10/31/20222,610,000 shares $61.39 million +1.6%6.6%7.8 $23.52 10/15/20222,570,000 shares $52.15 million +4.5%6.5%8.2 $20.29 9/30/20222,460,000 shares $55.97 million +2.1%6.3%7.5 $22.75 9/15/20222,410,000 shares $62.52 million +2.1%6.1%6.4 $25.94 8/31/20222,360,000 shares $55.72 million -2.9%6.0%6.2 $23.61“Retirement Secret” Showed 995% Gain Last Time We Shared It (Ad)See this before next week's Fed Meeting Thousands of investing ideas come across his desk every year… But Doc Eifrig just revealed THIS ONE "will go down as one of the smartest and most lucrative financial moves of the decade." (Last time we shared this, it led to a 995% gain.)Get the free details now. BLFS Short Interest - Frequently Asked Questions What is BioLife Solutions' current short interest? Short interest is the volume of BioLife Solutions shares that have been sold short but have not yet been closed out or covered. As of March 31st, investors have sold 3,200,000 shares of BLFS short. Learn More on BioLife Solutions' current short interest. What is a good short interest ratio for BioLife Solutions? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. BLFS shares currently have a short interest ratio of 8.0. Learn More on BioLife Solutions's short interest ratio. Which institutional investors are shorting BioLife Solutions? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of BioLife Solutions: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is BioLife Solutions' short interest increasing or decreasing? BioLife Solutions saw a increase in short interest in the month of March. As of March 31st, there was short interest totaling 3,200,000 shares, an increase of 5.6% from the previous total of 3,030,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does BioLife Solutions' short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to BioLife Solutions: Zynex, Inc. (31.73%), AxoGen, Inc. (4.26%), Edap Tms S.A. (0.28%), Soleno Therapeutics, Inc. (14.60%), Outset Medical, Inc. (16.17%), InMode Ltd. (7.04%), CONMED Co. (13.22%), TransMedics Group, Inc. (18.31%), LivaNova PLC (6.13%), Relay Therapeutics, Inc. (8.52%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.49 billion), T-Mobile US, Inc. ($3.94 billion), General Motors ($3.34 billion), Charter Communications, Inc. ($3.32 billion), Occidental Petroleum Co. ($3.21 billion), Super Micro Computer, Inc. ($3.13 billion), Coinbase Global, Inc. ($3.08 billion), Moderna, Inc. ($2.28 billion), Tractor Supply ($2.24 billion), and Royal Caribbean Cruises Ltd. ($2.14 billion). View all of the most shorted stocks. What does it mean to sell short BioLife Solutions stock? Short selling BLFS is an investing strategy that aims to generate trading profit from BioLife Solutions as its price is falling. BLFS shares are trading up $0.17 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against BioLife Solutions? A short squeeze for BioLife Solutions occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of BLFS, which in turn drives the price of the stock up even further. How often is BioLife Solutions' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BLFS, twice per month. The most recent reporting period available is March, 31 2024. More Short Interest Resources from MarketBeat Related Companies: Zynex Short Squeeze AxoGen Short Squeeze Edap Tms Short Squeeze Soleno Therapeutics Short Squeeze Outset Medical Short Squeeze InMode Short Squeeze CONMED Short Squeeze TransMedics Group Short Squeeze LivaNova Short Squeeze Relay Therapeutics Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:BLFS) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarThe A.I. story nobody is telling you (Read ASAP)TradeSmith“The Biggest Bubble of All Time” – Here’s What to Do.Chaikin Analyticstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyBetter than Bitcoin? The Biotech Stock with 46,751% PotentialBehind the MarketsPrepare for a recession unlike any otherAmerican Hartford Gold Group